Reset filter
Trefwoorden
AML ×
Meer tonen Trefwoorden
Inhoudsopgave
  1. 1. Estudo clínico
  2. 2. Documentação de rotina
  3. 3. Estudos de registo/coortes
  4. 4. Garantia da qualidade
  5. 5. Padrão de dados
  6. 6. Questionário do paciente
  7. 7. Especialidade médica
Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

269 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Leukemia NCT01041703 Eligibility - E2906 Registration Worksheet (step 1) - 3082845v1.0 - E2906 Registration Worksheet (step 1)

- 09/01/2015 - 1 Formulier, 1 Itemgroep, 16 Data-elementen, 1 Taal
Itemgroep: Eligibility
E2906 Registration Worksheet (step 1) Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=85FA2555-1EC1-F884-E040-BB89AD432656

Leukemia NCT01041703 Eligibility - E2906 Registration Worksheet (step 2) - 3083300v1.0 - E2906 Registration Worksheet (step 2)

- 09/01/2015 - 1 Formulier, 1 Itemgroep, 3 Data-elementen, 1 Taal
Itemgroep: Eligibility
E2906 Registration Worksheet (step 2) Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8605B765-B230-3E8A-E040-BB89AD4310BC

Leukemia NCT01041703 Treatment - E2906 Baseline Data Form - Step 3 - 3177877v1.0 - E2906 Baseline Data Form - Step 3

- 09/01/2015 - 1 Formulier, 8 Itemgroepen, 61 Data-elementen, 1 Taal
Itemgroepen: Header Module, Reporting Period, Header, Pre-registration Evaluation, Bone Marrow, Pre-registration Hematology/Chemistry, Baseline Abnormalities, Footer Module
E2906 Baseline Data Form - Step 3 Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9805CBE8-D299-9B64-E040-BB89AD431E80

On-Study - Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS) - On-Study Form - Relapse/Refractory Treatment - 2019378v3.0 - Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS) - On-Study Form - Relapse/Refractory Treatment

- 09/01/2015 - 1 Formulier, 4 Itemgroepen, 28 Data-elementen, 1 Taal
Itemgroepen: CRF Header, AML/MDS: Form Administration, AML/MDS: Disease Description, Comments
Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS) - On-Study Form - Relapse/Refractory Treatment Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1B24FD93-54A8-51C5-E044-0003BA3F9857

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS) - On-Study Form - RelapseRefractory Treatment 2019378_v3_0 - Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS) - On-Study Form - Relapse/Refractory Treatment

- 09/01/2015 - 1 Formulier, 4 Itemgroepen, 28 Data-elementen, 2 Talen
Itemgroepen: CRF Header, AML/MDS: Form Administration, AML/MDS: Disease Description, Comments
Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS) - On-Study Form - Relapse/Refractory Treatment Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1B24FD93-54A8-51C5-E044-0003BA3F9857

Leukemia NCT01041703 Treatment - E2906 Engraftment Form - Arm G - 2951586v1.0 - E2906 Engraftment Form - Arm G

- 08/01/2015 - 1 Formulier, 6 Itemgroepen, 28 Data-elementen, 1 Taal
Itemgroepen: Header Module, Reporting Period, Header, Vital Status, Engraftment, Footer Module
E2906 Engraftment Form - Arm G Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7583518B-5574-8F0A-E040-BB89AD437B26

Follow-Up - Acute Leukemia (AML/ALL/APL) - Follow-Up Form - 2019373v3.0 - Acute Leukemia (AML/ALL/APL) - Follow-Up Form

- 08/01/2015 - 1 Formulier, 6 Itemgroepen, 24 Data-elementen, 1 Taal
Itemgroepen: CRF Header, AML/ALL/APL: Form Administration, AML/ALL/APL: Vital Status, AML/ALL/APL: Disease Follow-Up Status, AML/ALL/APL: Notice of Progression, Comments
Acute Leukemia (AML/ALL/APL) - Follow-Up Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1AB0D69C-1E03-0A07-E044-0003BA3F9857

Leukemia NCT01041703 Follow-Up - E2906 Long-Term Follow-up Form - 2947429v1.0 - E2906 Long-Term Follow-up Form

- 08/01/2015 - 1 Formulier, 9 Itemgroepen, 34 Data-elementen, 1 Taal
Itemgroepen: Header Module/Off-Treatment Report Period, Header, Section 1 - Vital Status, Section II - Reporting Period, Section III - Notice of New Primary, Section IV - Disease Follow-up Status, Section V - Adverse Events, Section VI - Non-Protocol Therapy Prior To Progression, Footer Module
E2906 Long-Term Follow-up Form Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=74BCE806-5598-4D7A-E040-BB89AD437934

Leukemia NCT01041703 Treatment - E2906 Treatment Form - INDUCTION - Arm A - Step 1 - 2948839v1.0 - E2906 Treatment Form - INDUCTION - Arm A - Step 1

- 08/01/2015 - 1 Formulier, 11 Itemgroepen, 36 Data-elementen, 1 Taal
Itemgroepen: Header Module, Reporting Period, Header, Reporting Period1, Vital Status, Patient Characteristics, Induction Therapy Administered, Induction Therapy Administered1, Other Therapy Administered, Non-Protocol Therapy, Footer Module
E2906 Treatment Form - INDUCTION - Arm A - Step 1 Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=74CE8E4B-E13E-C2ED-E040-BB89AD436D94

Studienende / Studienabbruch EudraCT 2008-004583-40 Akute myeloische Leukämie(AML) AML alle außer FAB M3 - Studienende / Studienabbruch

- 22/12/2014 - 1 Formulier, 3 Itemgroepen, 10 Data-elementen, 2 Talen
Itemgroepen: Study end, Early termination of clinical trial, Unterschrift
A randomized, multi-center phase II trial to assess the efficacy of 5-azacytidine added to standard primary therapy in elderly patients with newly diagnosed AML

Tag 35 nach Beginn der letzten Induktionstherapie

- 22/12/2014 - 1 Formulier, 1 Itemgroep, 4 Data-elementen, 2 Talen
Itemgroep: Regeneration of blood cell count
A randomized, multi-center phase II trial to assess the efficacy of 5-azacytidine added to standard primary therapy in elderly patients with newly diagnosed AML

Eligibility AZD1152 and LDAC in AML

- 16/12/2014 - 1 Formulier, 2 Itemgroepen, 8 Data-elementen, 1 Taal
Itemgroepen: Inclusion criteria, Exclusion criteria
ODM derived from http://clinicaltrials.gov/ct2/show/record/NCT00952588

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial